Cargando…

Maximizing the Outcomes in Cancer Patients Receiving

Detalles Bibliográficos
Autores principales:	Mucenski, John W., Shogan, Jeffrey E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2003
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437162/ https://www.ncbi.nlm.nih.gov/pubmed/14613339 http://dx.doi.org/10.18553/jmcp.2003.9.s2.10

Ejemplares similares

Continuing Education
por: Chrischilles, Elizabeth A., et al.
Publicado: (2003)

Curbing Resistance Development:Maximizing the Utility of Available Agents
por: Burgess, David S.
Publicado: (2009)

Introduction: Targeted Evidenced-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Minkoff, Neil B.
Publicado: (2007)

Identifying Indicators of Outcomes and Implementing Treatment Pathways
por: Huff, Carol Ann, et al.
Publicado: (2012)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care
por: Bugos, Kelly G., et al.
Publicado: (2012)

Strategies for Optimizing Treatment Outcomes
por: Jones Freeman, Elyce L.
Publicado: (2003)

Improving Cost-Effectiveness of and Outcomes From Drug Therapy in Patients With Atrial Fibrillation in Managed Care: Role of the Pharmacist
por: Johnson, Samuel G.
Publicado: (2009)

Assessment of Disease Activity and Treatment Outcomes in Rheumatoid Arthritis
por: Farheen, Kiran, et al.
Publicado: (2011)

Medicare Challenges and Solutions - reimbursement Issues in Treating the Patient with Colorectal Cancer
por: Kaa, Kathleen
Publicado: (2007)

The Role of Outcomes Research in Defining and Measuring Value in Benefit Decision
por: Nichol, Michael B.
Publicado: (2006)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)

Influencing Patient Adherence to Treatment Guidelines
por: Butterworth, Susan W.
Publicado: (2008)

Introduction
por: Dunn, Jeffrey D.
Publicado: (2012)

Pharmacy Management Approach: How Do We Align All the Incentives?
por: Dunn, Jeffrey D.
Publicado: (2007)

Primary Care Physician Perspective on Management of Patients with Depression
por: Ford, Daniel E.
Publicado: (2006)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

Colorectal Cancer: Complexities and Challenges in Managed Care
por: Minkoff, Neil
Publicado: (2007)

Epidemiology, disease Progression, and Economic Burden of Colorectal Cancer
por: Benson, Al
Publicado: (2007)

Managing Depressed Patients
por: Arizpe, Michael
Publicado: (2006)

Patient Centric Care Management
por: Chao, Scumarry H.
Publicado: (2006)

Assessing Resource Use in Oncology Patients
por: Semroc, Georgette N., et al.
Publicado: (2003)

The patient Experience with the mental Health System
por: Wittwer, Sherri D.
Publicado: (2006)

Promoting Health and Productivity for Depressed Patients in the Workplace
por: Sullivan, Sean
Publicado: (2005)

Analysis of the Current Care Model of the COPD Patient
por: Minkoff, Neil B.
Publicado: (2005)

Introduction
por: Rumsfeld, John S.
Publicado: (2006)

Guidelines and Performance Measures for the Prevention and Treatment of Venous Thromboembolism
por: Fanikos, John
Publicado: (2008)

Practice Strategies to Improve Compliance and Patient Self-Management
por: Ruetsch, Charles
Publicado: (2010)

Epidemiology and Unmet Needs in Hypertension
por: Flack, John M.
Publicado: (2007)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

Treatment-Resistant Depression: Managed Care Considerations
por: Tierney, John G.
Publicado: (2007)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials
por: Foley, John F., et al.
Publicado: (2013)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)

Applications of Disease Benchmarks and Case Presentations
por: Pill, Michael W.
Publicado: (2005)

Introduction
por: Cosler, Leon E.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_u05raevivv3lr3jk15hbi1lmtt